Generation of Synthetic Patient Data (RAW) for Risk Evaluation of Bone Metastases Derived From Carcinoma
Trial Snapshot
- Phase
- Not Applicable
- Status
- Recruiting
- Sponsor
- Enrollment
- 250
- Locations
- 1
- Primary Endpoint
- Creation a dataset of clinical data and diagnostic images
Study Overview
Brief Summary
From the archives of the Rizzoli institute all patients (approximately 750) treated for bone metastases from 01/01/2010 to 31/12/2022.
A review will be made from the medical records, radiological imaging, and histological data of these patients
Study Design
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Retrospective
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Age ≥ 18 years
- •Diagnosis of bone metastasis from carcinoma, regardless of the type of carcinoma, and of the number and location of the metastases
- •Availability of imaging and clinical data
- •Availability of at least one follow-up during the last 12 months form diagnosis
Exclusion Criteria
- •At least one inclusion creteria not met
Outcomes
Primary Outcomes
Creation a dataset of clinical data and diagnostic images
Time Frame: At baseline (Day 0)
Creation a dataset of clinical data and diagnostic images, called RAW, relating to patients suffering from metastatic bone cancer that will be used by the unit UNICH to create innovative models for fracture risk prediction and of life expectancy based on various patient clinical parameters.
Secondary Outcomes
No secondary outcomes reported
Investigators
Costantino Errani
MD
Istituto Ortopedico Rizzoli
